Scholarlink

<p>Central nervous system complications (CNSC) after allogeneic hematopoietic cell transplantation (allo-HCT) are relatively common and may have a major impact on patients´ outcomes. Neurological symptoms may occur at any point during the post-transplant course, although they are more common early after HCT, with a wide range of possible presentations. As many of CNSC symptoms are non-specific, the initial assessment is often difficult, and early decisions regarding the diagnostic work-up can influence the identification of the underlying cause. Blood tests, neuroimaging and cerebrospinal fluid (CSF) analyses are particularly important, as they frequently provide the first clues that help narrow the very wide differential diagnoses. In view of these challenges, an international EBMT working group composed of haematologists, infectious disease specialists, neurologists, a neuroradiologist, and a microbiologist developed symptom-based recommendations for the early evaluation of CNSC after allo-HCT. The work summarizes key aspects of the clinical presentation and outlines practical steps for the initial diagnostic approach. These recommendations are intended to support haematologists, who are usually the first to assess these patients, in promptly recognizing CNSC so to start timely appropriate management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee

  • 期刊论文

  • 发表日期：

    2026年5月7日

查看全文
  • Roser Velasco,
  • Martin Schmidt-Hieber,
  • Olaf Penack,
  • Dina Averbuch,
  • Aitana Balaguer-Roselló,
  • Francesco Baccelli,
  • Luis Bataller,
  • Simone Cesaro,
  • Chiara Briani,
  • Rafael de la Cámara,
  • Petra Huehnchen,
  • Thushan de Silva,
  • Alberto Mussetti,
  • Per Ljungman,
  • Zinaida Perić,
  • Malgorzata Mikulska,
  • Alexey Polushin,
  • David Navarro Ortega,
  • Albert Pons-Escoda,
  • Dionysios Neofytos,
  • Hélène Schoemans,
  • José Luis Piñana,
  • Francesco Onida,
  • Annalisa Ruggeri,
  • Isabel Sanchez-Ortega,
  • Ibrahim Yakoub-Agha,
  • Jan Styczynski

摘要

Central nervous system complications (CNSC) after allogeneic hematopoietic cell transplantation (allo-HCT) are relatively common and may have a major impact on patients´ outcomes. Neurological symptoms may occur at any point during the post-transplant course, although they are more common early after HCT, with a wide range of possible presentations. As many of CNSC symptoms are non-specific, the initial assessment is often difficult, and early decisions regarding the diagnostic work-up can influence the identification of the underlying cause. Blood tests, neuroimaging and cerebrospinal fluid (CSF) analyses are particularly important, as they frequently provide the first clues that help narrow the very wide differential diagnoses. In view of these challenges, an international EBMT working group composed of haematologists, infectious disease specialists, neurologists, a neuroradiologist, and a microbiologist developed symptom-based recommendations for the early evaluation of CNSC after allo-HCT. The work summarizes key aspects of the clinical presentation and outlines practical steps for the initial diagnostic approach. These recommendations are intended to support haematologists, who are usually the first to assess these patients, in promptly recognizing CNSC so to start timely appropriate management.